Advertisement
The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App
Professionals >> Visit The Body PROThe Body en Espanol
  Breaking News: FDA Approves Triumeq, New Once-Daily Combination Pill
   
Ask the Experts About

Hepatitis and HIV CoinfectionHepatitis and HIV Coinfection
           
Rollover images to visit our other forums!
Recent AnswersAsk a Question
  
  • Email Email
  • Glossary Glossary


reoccuring hepatitis c
Nov 18, 2007

took 14 months of 180units pegasys shot weekly took 5 200mg of copegasys daily the hepatitis showed back up in 4months

Response from Dr. McGovern

This must be a great disappointment for you. It sounds like you must have genotype 1 infection. I would also guess that you cleared your virus on the later side and your provider decided to treat you longer to give you the best chance of success. Your ribavirin dose is 1000 mg daily which appears to be a weight-based dosing (which is optimal).

I would wait for studies of newer drugs in the next few years.You will probably be an excellent candidate since it sounds like you were a responder in the first place. It would be my hope that the protease inhibitors or the polymerase inhibitors will be available to you and will help you achieve a rapid virologic response.



Previous
CDC
Next
Hepatit B infeksjon

  
  • Email Email
  • Glossary Glossary

 Get Email Notifications When This Forum Updates or Subscribe With RSS


 
Advertisement



Q&A TERMS OF USE

This forum is designed for educational purposes only, and experts are not rendering medical, mental health, legal or other professional advice or services. If you have or suspect you may have a medical, mental health, legal or other problem that requires advice, consult your own caregiver, attorney or other qualified professional.

Experts appearing on this page are independent and are solely responsible for editing and fact-checking their material. Neither TheBody.com nor any advertiser is the publisher or speaker of posted visitors' questions or the experts' material.

Review our complete terms of use and copyright notice.

Powered by ExpertViewpoint

Advertisement